GILD

141.11

0.13% -0.18

시간 외 거래: 141.25 0.14 +0.10%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$141.29

열려 있는:

$141.415

하루 거래량:

7.16M

Relative Volume:

1.01

시가총액:

$175.18B

수익:

$29.45B

순이익/손실:

$8.51B

주가수익비율:

20.81

EPS:

6.7823

순현금흐름:

$9.46B

1주 성능:

-2.82%

1개월 성능:

-6.62%

6개월 성능:

+23.68%

1년 성능:

+31.25%

1일 변동 폭

$140.12

$142.09

1주일 범위

$139.23

$148.22

52주 변동 폭

$93.37

$157.29

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1114)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,000

트위터

@GileadSciences

다음 수익 날짜

2026-04-23

최신 SEC 제출 서류

GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, AZN, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	141.11	175.40B	29.45B	8.51B	9.46B	6.7823
LLY Lilly Eli Co	917.50	819.81B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	237.60	571.52B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	206.23	368.38B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	188.93	292.21B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	148.19	285.86B	54.72B	14.02B	15.32B	7.1855

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-10	개시	Jefferies	Buy
2026-02-20	개시	Barclays	Equal Weight
2026-02-11	재확인	Needham	Buy
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

09:00 AM

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock - Yahoo Finance Singapore

09:00 AM

07:59 AM

Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd - MarketBeat

07:59 AM

05:31 AM

Investment Research Partners LLC Takes $928,000 Position in Gilead Sciences, Inc. $GILD - MarketBeat

05:31 AM

03:47 AM

Coldstream Capital Management Inc. Acquires 8,807 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

03:47 AM

Mar 18, 2026

Gilead Sciences (GILD) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance Australia

Mar 18, 2026

Ciara Is Bringing Back the Pop Culture PSA (Exclusive) - Cosmopolitan

Mar 18, 2026

Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN

Mar 18, 2026

Gilead Sciences initiates challenging study for aggressive breast cancer form - Traders Union

Mar 18, 2026

Antiretroviral Therapy Market Critical Analysis with Expert Opinion| Gilead Sciences, Viatris, AbbVie - openPR.com

Mar 18, 2026

Gilead Sciences Stock Performance vs. Business Health Analysis 2026News and Statistics - IndexBox

Mar 18, 2026

Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 18, 2026

Captrust Financial Advisors Has $211.80 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 18, 2026

Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V. - MarketBeat

Mar 18, 2026

Mar 17, 2026

Gilead Sciences CFO Dickinson sells $432k in stock - Investing.com

Mar 17, 2026

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares - MarketBeat

Mar 17, 2026

Insider Sell: Andrew Dickinson Sells Shares of Gilead Sciences I - GuruFocus

Mar 17, 2026

Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock - MarketBeat

Mar 17, 2026

Manta Cares and Gilead Sciences Announce Collaboration to Support Patients Navigating Metastatic Breast and Lung Cancer - Femtech Insider

Mar 17, 2026

Gilead Sciences ASCENT-04 regimen gains Category 1 status in updated NCCN guidelines - Traders Union

Mar 17, 2026

Manta Cares and Gilead Sciences Collaborate to Support Patients Navigating Metastatic Lung and Breast Cancer - PRWeb

Mar 17, 2026

Cantor Fitzgerald reiterates Gilead stock rating on Yeztugo sales - Investing.com

Mar 17, 2026

National Bank of Canada FI Has $161.14 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 17, 2026

Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Yahoo Finance

Mar 17, 2026

Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth - MarketBeat

Mar 17, 2026

Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 17, 2026

CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 17, 2026

Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 17, 2026

Mar 16, 2026

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool

Mar 16, 2026

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool

Mar 16, 2026

Gotham Asset Management Increases Gilead Sciences Stake - National Today

Mar 16, 2026

Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February - MarketBeat

Mar 16, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - MarketBeat

Mar 16, 2026

Gotham Asset Management LLC Has $38.40 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 16, 2026

Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 16, 2026

Gilead Sciences, Inc. (GILD): Growth prospects backed by analyst upgrades - MSN

Mar 16, 2026

Mar 15, 2026

Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades - Insider Monkey

Mar 15, 2026

Capitolis Liquid Global Markets LLC Invests $40.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

Chevy Chase Trust Holdings LLC Has $70.93 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

California Public Employees Retirement System Has $447.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Mar 15, 2026

Mar 14, 2026

Wellington Management Group LLP Has $2.84 Billion Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 14, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - MarketBeat

Mar 14, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oruka Therapeutics (ORKA), Radnet (RDNT) and Gilead Sciences (GILD) - The Globe and Mail

Mar 14, 2026

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Oruka Therapeutics (ORKA) and Gilead Sciences (GILD) - The Globe and Mail

Mar 14, 2026

Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Mar 14, 2026

Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen - MarketBeat

Mar 14, 2026

Mar 13, 2026

Precision Trading with Gilead Sciences Inc. (GILD) Risk Zones - Stock Traders Daily

Mar 13, 2026